Inventor

STACHEL SHAWN J

US33 patents

⚠️ This page may combine multiple inventors who share the name “STACHEL SHAWN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

STACHEL SHAWN J

MERCK SHARP & DOHME

2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors

Bicyclic heterocyclic compounds as PDE2 inhibitors

6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors

Cyanopyridine derivatives as liver X receptor beta agonists, compositions, and their use

TrkA kinase inhibitors, compositions and methods thereof

Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer&#39;s disease

Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use

N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use

Piperidine derivatives as liver X receptor beta agonists, compositions, and their use

3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer&#39;s disease

2,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer&#39;s Disease

2-aminopyridine compounds useful as β-secretase inhibitors for the treatment of alzheimer&#39;s disease

Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors

Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer&#39;s disease

MERCK & CO INC

Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer&#39;s disease

Macrocyclic β-secretase inhibitors for the treatment of Alzheimer&#39;s disease

N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer&#39;s disease

Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer&#39;s disease

Macrocyclic beta-secretase inhibitors for the treatment of Alzheimer&#39;s disease

Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer&#39;s disease

MERCK SHARP & DOHME LLC

Pyrrolidine orexin receptor agonists

2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors

2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors

2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors

SLOAN KETTERING INST CANCER

Macrocycles and uses thereof

Synthesis of epothilones, intermediates thereto and analogues thereof

COBURN CRAIG A

Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer&#39;s disease

LIU KUN

Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer&#39;S disease

HANNEY BARBARA

Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitors

SELNICK HAROLD G

Monocyclic CGRP receptor antagonists

WOOD MICHAEL R

Non-amidic linkers with branched termini as CGRP receptor antagonists

NANTERMET PHILIPPE G

2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer&#39;s disease

HILLS IVORY D

2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer&#39;s disease

Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease

3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease

2,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's Disease

2-aminopyridine compounds useful as β-secretase inhibitors for the treatment of alzheimer's disease

Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease

Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease

Macrocyclic β-secretase inhibitors for the treatment of Alzheimer's disease

N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease

Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease

Macrocyclic beta-secretase inhibitors for the treatment of Alzheimer's disease

Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease

Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease

2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease

2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease